Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Helga Koch
Observed names:
H K Koch,
H Koch,
H. Koch
Institution:
Merck KGaA, Darmstadt (Germany)
Observed institutions:
Merck KGaA, Darmstadt (Germany),
Johannes Gutenberg University Mainz,
University Hospital Regensburg,
University of Regensburg
OpenAlex ID:
A5078836070
Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials
2018
·
Karen Kelly
, Jeffrey R. Infante
, et al.
·
Cancer
·
97
PDF
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
2007
·
P. Hau
, D. Koch
, et al.
·
Neurology
·
95
Safety profile of avelumab in patients with advanced solid tumors: A JAVELIN pooled analysis of phase 1 and 2 data.
2017
·
Karen Kelly
, Jeffrey R. Infante
, et al.
·
Journal of Clinical Oncology
·
6
(1125) - Selective Activation of Naturally Occurring Regulatory T Cells (Tregs) by the Monoclonal Antibody (mAb) BT-061. Markers of Clinical Activity and Early Phase II Results in Patients with Rheumatoid Arthritis (RA)
2010
·
Anatoliy Rudnev
, Sukanya Ragavan
, et al.
·
6
Efficacy and safety of mitoxantrone in multiple sclerosis: a retrospective analysis of 105 patients
2005
·
A Spichtinger
, H Koch
, et al.
·
Aktuelle Neurologie
Adjuvant chemotherapy with temozolomide and liposomal doxorubicine in the first-line therapy of patients with glioblastoma - a phase-II trial
2004
·
P Hau
, T Jauch
, et al.
·
Aktuelle Neurologie
[Hemorrhage into a liver adenoma associated with long-term use of oral contraceptives].
1985
·
H J Brambs
, P Hoppe-seyler
, et al.
·
PubMed
Show more works
View as search
Works count:
7
Citation count:
204
H-index:
4
I10-index:
2
Year
Topic
Type